Bulletin
Investor Alert

Merck & Co. Inc.

NYS: MRK

GO
/marketstate/country/us

After Hours

MRK
/zigman2/quotes/209956077/composite

$

73.36

Change

+0.02 +0.03%

Volume

Volume 1.17m

Dec 3, 2021, 7:59 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/209956077/composite

Previous close

$ 73.89

$ 73.34

Change

-0.55 -0.74%

Day low

Day high

$72.66

$74.25

Open
Open: 74.09

52 week low

52 week high

$68.38

$91.40

Open

Market cap

$185.25B

Average volume

17.10M

P/E ratio

25.89

Rev. per Employee

$648,824

EPS

2.83

Dividend

0.65

Div yield

3.76%

Ex dividend date

6/14/21

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/mrk

MarketWatch News on MRK

  1. Bristol Stock Is Too Cheap. Why It Could Be Ready to Rally.

    8:57 p.m. Today

    - Ben Levisohn

  2. Johnson & Johnson stock outperforms competitors on strong trading day

    4:32 p.m. Dec. 3, 2021

    - MarketWatch Automation

  3. Merck to supply Canada with up to 1 mln courses of COVID-19 pill

    2:20 p.m. Dec. 3, 2021

    - Tomi Kilgore

  4. Johnson & Johnson stock falls Thursday, underperforms market

    4:32 p.m. Dec. 2, 2021

    - MarketWatch Automation

  5. Johnson & Johnson stock outperforms market on strong trading day

    4:32 p.m. Dec. 1, 2021

    - MarketWatch Automation

  6. FDA Advisors Vote Narrowly in Favor of Merck Covid Pill

    8:33 a.m. Dec. 1, 2021

    - Josh Nathan-Kazis

  7. Johnson & Johnson stock underperforms Tuesday when compared to competitors

    4:32 p.m. Nov. 30, 2021

    - MarketWatch Automation

  8. Stock Market Jitters Continue Over Covid. It's Too Early to Panic.

    9:57 a.m. Nov. 30, 2021

    - Josh Nathan-Kazis

  9. Merck's Covid Pill Gets an FDA Hearing Today. What's at Stake.

    8:28 a.m. Nov. 30, 2021

    - Josh Nathan-Kazis

  10. Merck’s sNDA for breast cancer treatment Lynparza was granted priority review by the FDA

    6:32 a.m. Nov. 30, 2021

    - Tomi Kilgore

  11. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/mrk

Other News on MRK

  1. J&J, Pfizer, Novartis Among Pharma Giants With Biggest War Chests

    2:14 p.m. Today

    - GuruFocus.com

  2. Diversify, Diversify - Concentration Risks Of Several Pharma Companies

    9:43 a.m. Today

    - Seeking Alpha

  3. Dividend Champion, Contender, And Challenger Highlights: Week Of December 5

    12:58 a.m. Today

    - Seeking Alpha

  4. 2 Rich Dividends To Buy Before The Santa Claus Rally

    9:00 a.m. Dec. 4, 2021

    - Seeking Alpha

  5. Dogs Of The Dow Hit December Sporting 2 To Buy

    4:27 a.m. Dec. 4, 2021

    - Seeking Alpha

  6. Merck's Selloff Is an Overreaction

    10:28 a.m. Dec. 3, 2021

    - GuruFocus.com

  7. Early Stage COVID Treatments: Merck's Molnupiravir Struggles

    9:10 a.m. Dec. 3, 2021

    - Seeking Alpha

  8. Dividend Champions For December 2021

    8:56 p.m. Dec. 2, 2021

    - Seeking Alpha

  9. 3 Stocks to Buy for the New COVID Variant

    4:00 p.m. Dec. 2, 2021

    - Motley Fool

  10. Merck, Novartis in Line for Key FDA Approvals This Month

    2:30 p.m. Dec. 2, 2021

    - GuruFocus.com

  11. Loading more headlines...
/news/pressrelease/company/us/mrk

Press Releases on MRK

  1. How To Trade Merck MRK

    12:33 a.m. Dec. 4, 2021

    - Stock Traders Daily

  2. Hot Stocks To Buy Right Now? 3 Health Care Stocks To Know

    1:18 p.m. Dec. 3, 2021

    - StockMarket.com

  3. Dow Movers: AAPL, BA

    10:11 a.m. Dec. 2, 2021

    - MarketNewsVideo.com

  4. Daily Dividend Report: MRK,VGR,RY,MKC,MA

    12:01 p.m. Dec. 1, 2021

    - MarketNewsVideo.com

  5. Merck Vaults on FDA Nod

    10:12 a.m. Dec. 1, 2021

    - Baystreet.ca

  6. Top Stock Market News For Today December 1, 2021

    6:42 a.m. Dec. 1, 2021

    - StockMarket.com

  7. Merck Announces First-Quarter 2022 Dividend

    2:48 p.m. Nov. 30, 2021

    - BusinessWire - BZX

  8. Loading more headlines...

Rates »

Trending Tickers
  • /zigman2/quotes/200467500/composite NVDA+6.01%
  • /zigman2/quotes/200164174/composite SNOA+85.40%
  • /zigman2/quotes/202092269/composite ENSC+35.46%
  • /zigman2/quotes/226465160/composite ALF-14.72%
  • /zigman2/quotes/207732364/composite MSFT+1.66%
X
Powered by StockTwits
Link to MarketWatch's Slice.